Stroke is a leading cause of death in New Zealand, with increasing incidence amongst Māori and Pacific people, and has enormous impact in our communities. Among those who survive a stroke many are left with some level of disability.
Stroke and TIA prevention and adequate control of modifiable risk factors is a focus for primary care, as well as the management of ongoing deficits and related health issues after stroke.
Professor Alan Barber and Professor Valery Feigin will present clinical updates on stroke and TIA, and look at some relevant clinical cases. They will also present on the Auckland Regional Community Outcomes of Stroke (ARCOS) studies that have helped our understanding of stroke.
Presenter
Professor Alan Barber
Alan is Director of Auckland City Hospital Stroke Service, Neurological Foundation of NZ, Professor of Clinical Neurology, Department of Medicine, University of Auckland, New Zealand. He graduated from the Otago Medical School and completed his neurology training in Auckland, New Zealand in 1997. He was awarded a PhD from the University of Melbourne in 2000. His thesis examined the role of advanced imaging techniques in identifying patients with the potential to respond to acute stroke therapies. He returned to New Zealand in 2001 and has established a stroke unit at Auckland City Hospital. His research interests cover the full spectrum of stroke care from prevention, acute management and rehabilitation. He was appointed the Neurological Foundation of New Zealand Professor of Clinical Neurology in 2008.
Presenter
Professor Valery Feigin
Professor of Neurology and Epidemiology and the Director of the National Institute for Stroke and Applied Neurosciences, Faculty of Health and Environmental Sciences at the AUT University of Auckland, and Affiliate Professor of the Department of Global Health at the Institute for Health Metrics and Evaluation at the University of Washington, USA. Valery is also Honorary Professor of the Novosibirsk State Medical University, Russia, a Visiting Professor of the Capital Medical University of China, a Fellow of the Royal Society of New Zealand, American Academy of Neurology, American Heart Association, and Russian Academy of Sciences.
Valery’s prime research interest is in the epidemiology, prevention and management of stroke, dementia and traumatic brain injury. Valery is held in high public esteem for his innovative epidemiological and primary stroke prevention work, including the Stroke Riskometer app, a new motivational mass stroke prevention strategy using validated and internationally recognised mobile technology implemented in >70 countries. This new paradigm in primary stroke prevention is now a flagship project of the World Stroke Organization. He has published over 650 research articles (>360 in journals, including 75 in The Lancet), 10 handbooks on stroke, epidemiology and public health and 18 book chapters. His current (January 2020) Scopus h-index is 82, with over 63,700 citations.
He is Editor-in-Chief of the journal Neuroepidemiology and a member of the Editorial Boards of 10 international medical journals. He is also a Director on the Board of Directors and Executive Committee member of the World Stroke Organization, and WHO expert on stroke.
